INC280

Known as: INCB028060 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
02420112015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Non-small cell lung cancer patients carrying oncogenic EGFR mutations initially respond to EGFR-targeted therapy, but later… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Synovial sarcoma (SS) is an aggressive soft tissue sarcoma with a poor prognosis and, thus, novel therapeutic strategies for SS… (More)
Is this relevant?
2016
2016
BACKGROUND/AIMS The hepatocyte growth factor/transmembrane tyrosine kinase receptor c-Met has been defined as a potential target… (More)
Is this relevant?
2016
2016
The receptor tyrosine kinase mesenchymal-epithelial transition factor (c-Met) sits at the interface between controlled cellular… (More)
Is this relevant?
2015
2015
Expression and activation of the cMET receptor have been implicated in tumor progression and resistance to chemotherapy in human… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
5-year survival rates for ovarian cancer are approximately 40%, and for women diagnosed at late stage (the majority), just 27… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2015
Review
2015
BACKGROUND Cellular-mesenchymal-epithelial transition (MET) protein has recently been identified as a novel target that shows… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 3
Is this relevant?
2014
2014
Epithelioid sarcoma (EpS) is a high-grade malignant soft-tissue sarcoma characterized by local recurrences and distant metastases… (More)
Is this relevant?
2013
2013
The study reported in the article by Smith et al that accompanies this editorial presents data on a novel orally bioavailable… (More)
Is this relevant?
2011
2011
3091 Background: INCB028060 is a potent and selective inhibitor of c-MET receptor tyrosine kinase (RTK). This first-in-human… (More)
Is this relevant?